Polsinelli Represents Trially Inc. in $4.7M Series Seed Financing

Polsinelli congratulates its client, Trially Inc., on its $4.7 Million Series Seed financing. Trially Inc. is a data science and AI company that brings life-saving treatments to patients faster through HIPAA-compliant LLM agents.

The financing enables Trially to accelerate adoption of its AI-powered clinical trial recruitment platform across research sites, pharmaceutical sponsors, CROs and physician networks. This funding supports the rollout of its agentic AI solution, Margo, which transforms patient matching and enrollment into a faster, more accurate process—helping reduce costly delays and improve access to life-saving treatments.

More information about the financing can be obtained from Trially Inc.’s announcement.

The Polsinelli Venture Capital and Emerging Growth Companies team involved in the transaction included Chris Simpson, Laura Venn and Izzy Drake.